This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2018
Title: Dana Chuderland: Innovator in Nuclear Targeting Sequences
Introduction
Dana Chuderland is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of biotechnology, particularly in the area of nuclear targeting sequences. With a total of 3 patents to his name, Chuderland's work has the potential to impact various pharmaceutical applications.
Latest Patents
Chuderland's latest patents focus on isolated peptides that possess nuclear targeting activity or can prevent endogenous nuclear targeting activity. These patents disclose polynucleotides encoding the peptides, pharmaceutical compositions that include these peptides, and various uses for these innovations. His work in this area is crucial for advancing targeted therapies in medicine.
Career Highlights
Chuderland is affiliated with Yeda Research and Development Co. Ltd., where he continues to push the boundaries of scientific research. His innovative approach and dedication to his work have established him as a key figure in his field.
Collaborations
Chuderland collaborates with Rony Seger, a talented woman in the same research environment. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.
Conclusion
Dana Chuderland's contributions to the field of nuclear targeting sequences highlight his role as an influential inventor. His patents and ongoing research promise to advance the understanding and application of targeted therapies in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile